Effect of Antihypertensive Agent Choice on Parkinson’s Disease Progression in Patients with Hypertension
Objective: To determine the effect of different classes of antihypertensive medications on Parkinson’s disease progression. Background: Cardiovascular risk factors such as hypertension can worsen Parkinson’s…Transcutaneous Vagus Nerve Stimulation for Gait and Motor Function in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Objective: To evaluate the effects of transcutaneous vagus nerve stimulation (tVNS) on gait, motor function, and freezing of gait (FOG) in patients with Parkinson’s disease…Updated Meta-analysis Assessing GLP-1 Agonists for Parkinson’s Disease
Objective: Evaluate the efficacy and safety of Glucagon-like peptide-1 (GLP-1) agonists on Parkinson’s disease (PD). Background: The idea of repositioning drugs used to treat PD…Serum based estimations of CFAH, Gelsolin, CNDP1 and DKK3 levels suggest involvement of multiple pathways in pathogenesis of Parkinson’s disease.
Objective: To estimate levels of complement factor H (CFAH), phosphorylated alpha-syn (p- a-syn), gelsolin, carnosine dipeptidase-1 (CNDP1) and DKK3 in serum of Parkinson’s disease (PD) patients…Basal Ganglia Physiomarkers of Non-motor Symptoms in Parkinson’s Disease: a Systematic Review
Objective: To systematically review the evidence linking basal ganglia local field potentials to non-motor symptoms in Parkinson’s disease. Background: Deep brain stimulation for Parkinson’s disease…Quantitative Measures of Cutaneous Phosphorylated Alpha-Synuclein: Powering a Disease Modification Clinical Trial In Parkinson’s Disease
Objective: To use a novel quantitative assessment of cutaneous P-SYN in a pilot study of patients with Parkinson’s disease (PD) and healthy volunteers (HVs) to…Relationship Between Motor Subtypes and Central and Peripheral Neurodegeneration in Early Parkinson’s Disease: A Study Using DAT SPECT and SUDOSCAN
Objective: To investigate the relationship between Parkinson’s disease (PD) motor subtypes and neurodegeneration in both the central and peripheral nervous systems using dopamine transporter single-photon emission…Enhancing Parkinson’s Disease Detection Through Chemical and Motor Biomarkers
Objective: To assess the relationship between gait performance and the noninvasive detection of gaseous biomarkers emitted from the skin in denovo persons with Parkinson's disease…Cognitive Improvement in Parkinson’s Disease Patients After Intravenous Mesenchymal Stem Cell Infusion: Results from a Phase 2 Randomized Trial
Objective: Assess the impact of treatment with intravenous (IV) allogeneic bone marrow-derived mesenchymal stem cells (allo-hMSCs) on cognition in patients with mild-moderate Parkinson’s Disease (PD).…The East London Parkinson Disease Project: cultural fairness of common cognitive screening tests
Objective: The first objective of this work was to report the prevalence of Parkinson’s disease (PD) cognitive impairment in three ethnicities from the East London…
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 436
- Next Page »